Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCURAY INCARAY · Entity 1170 | Director | November 30, 2020 | December 02, 2020 |
| Alector, Inc.ALEC · Entity 6051 | Director | June 17, 2026 | June 17, 2026 |
| Assertio Therapeutics, IncASRT · Entity 149352 | Director | May 07, 2019 | May 09, 2019 |
| DOCUSIGN, INC.DOCU · Entity 2242 | Director | June 17, 2019 | June 19, 2019 |
| NovoCure LtdNVCR · Entity 4494 | Director | May 31, 2017 | June 05, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCURAY INC
Report date November 30, 2020 · Filed December 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 282,329 |
Reported balance
After 2020-11-30 transaction · row 1
1 source rowRow 1 · 2020-11-30 · Grant · Acquired 33,632 · Balance 282,329 F1: This represents a Restricted Stock Unit that vest 100% on 11/20/2021. |
Filing footnotes · ownership attribution and instrument terms
F1: This represents a Restricted Stock Unit that vest 100% on 11/20/2021.
Alector, Inc.
Report date June 17, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 128,109 |
Reported balance
After 2026-06-17 transaction · row 1
1 source rowRow 1 · 2026-06-17 · Grant · Acquired 28,700 · Balance 128,109 F1: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-06-16 | Direct | 9,450 |
Reported balance
After 2026-06-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-17 · Grant · Acquired 9,450 · Balance 9,450 F3: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 10,552 |
Reported balance
Holding disclosure · report date 2026-06-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,552 F2: The shares held of record by Lavrite, LLC, for which the reporting person serves as managing director. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders.
F2: The shares held of record by Lavrite, LLC, for which the reporting person serves as managing director.
F3: The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.
Assertio Therapeutics, Inc
Report date May 07, 2019 · Filed May 09, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,296 |
Reported balance
After 2019-05-07 transaction · row 1
1 source rowRow 1 · 2019-05-07 · Exercise / conversion · Acquired 31,250 · Balance 58,296 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2019-05-07 | Direct | 0 |
Reported balance
After 2019-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-07 · Exercise / conversion · Disposed 31,250 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock. F2: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock.
F2: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
DOCUSIGN, INC.
Report date June 17, 2019 · Filed June 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,542 |
Reported balance
After 2019-06-17 transaction · row 1
1 source rowRow 1 · 2019-06-17 · Grant · Acquired 3,791 · Balance 16,542 F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of June 17, 2019, in each case subject to the reporting person being a service provider through each such date. |
| Common StockSEC Table I · non-derivative | IndirectBy Trusts | 71,557 |
Reported balance
Holding disclosure · report date 2019-06-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 71,557 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 47,346 |
Reported balance
Holding disclosure · report date 2019-06-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 47,346 F2: The shares are held by Spring Development Group, LLC. The reporting person is the managing member of Spring Development Group, LLC and has sole voting and dispositive power over the shares held by Spring Development Group, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of June 17, 2019, in each case subject to the reporting person being a service provider through each such date.
F2: The shares are held by Spring Development Group, LLC. The reporting person is the managing member of Spring Development Group, LLC and has sole voting and dispositive power over the shares held by Spring Development Group, LLC.
NovoCure Ltd
Report date May 31, 2017 · Filed June 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to Buy Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $31.45 · Expires 2028-05-31 | Direct | 12,345 |
Reported balance
After 2018-05-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-31 · Grant · Acquired 12,345 · Balance 12,345 F1: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 6,145 |
Reported balance
After 2018-05-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-05-31 · Grant · Acquired 6,145 · Balance 6,145 F2: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.
F2: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.
F3: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ZYNGA INC
Report date May 23, 2022 · Filed May 24, 2022
Section 16 reporting ended · disclosed 2022-05-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-23 transaction · row 1
1 source rowRow 1 · 2022-05-23 · Disposition to issuer · Disposed 5,548 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 0 |
Reported balance
After 2022-05-23 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2022-05-23 · Disposition to issuer · Disposed 278,516 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock. F2: Shares are held by the Louis J. Lavigne, Jr. Survivor's Trust UAD 05/17/11. The Reporting Person serves as trustee and retains voting and dispositive power with respect to these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock.
F2: Shares are held by the Louis J. Lavigne, Jr. Survivor's Trust UAD 05/17/11. The Reporting Person serves as trustee and retains voting and dispositive power with respect to these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2019 Filed Apr 30, 2019 18:05 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026644 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 14,535 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 18:05 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-026644 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 11, 2019 Filed Feb 12, 2019 00:09 UTC | Alector, Inc. ALEC · Entity 6051 | ConversionSeries E Preferred Stock · Derivative | 10,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009114 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 10,552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series E Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. F1 · derivative.exercise_date: The Series E Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. F1 · derivative.expiration_date: The Series E Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. F2 · ownership.nature: The shares are held of record by Lavrite, LLC, for which the Reporting Person serves as a managing director. Read SEC document |
| February 11, 2019 Filed Feb 12, 2019 00:09 UTC | Alector, Inc. ALEC · Entity 6051 | ConversionCommon Stock | 10,552 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-009114 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series E Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. F2 · ownership.nature: The shares are held of record by Lavrite, LLC, for which the Reporting Person serves as a managing director. Read SEC document |
| January 26, 2019 Filed Jan 29, 2019 18:13 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-005868 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,535 Underlying: Class A Common Stock · 14,535 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| January 26, 2019 Filed Jan 29, 2019 18:13 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-005868 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| November 30, 2018 Filed Dec 7, 2018 01:29 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 36,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-18-000127 · edgardoc.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,996 F1 · kind: All of the restricted stock units vest on November 16, 2019. F2 · shares: This grant is represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of ARAY common stock. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:10 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 11,651 | $4.46 | $51,963.46 |
DisclosureSEC source: 0001138723-18-000087 · edgardoc.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,411 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 18:55 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-056477 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,070 Underlying: Class A Common Stock · 14,535 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| October 26, 2018 Filed Oct 29, 2018 18:55 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-056477 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| July 26, 2018 Filed Jul 26, 2018 18:13 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 14,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044085 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,605 Underlying: Class A Common Stock · 14,534 shares Expires 2025-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| July 26, 2018 Filed Jul 26, 2018 18:13 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 14,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044085 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| July 18, 2018 Filed Jul 20, 2018 22:50 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | GrantCommon Stock | 3,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-043556 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,403 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of July 18, 2018, in each case subject to the reporting person being a service provider through each such date. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:07 UTC | NovoCure Ltd NVCR · Entity 4494 | GrantRestricted Stock Unit · Derivative | 6,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035379 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,145 Underlying: Ordinary Shares · 6,145 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 00:07 UTC | NovoCure Ltd NVCR · Entity 4494 | GrantOptions to Buy Ordinary Shares · Derivative | 12,345 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001209191-18-035379 · doc4.xml · derivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,345 Underlying: Ordinary Shares · 12,345 shares Expires 2028-05-31 F1 · derivative.exercise_date: Options to buy 12,345 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2019 annual general meeting of shareholders. Read SEC document |
| May 15, 2018 Filed Feb 14, 2019 21:18 UTC | Assertio Therapeutics, Inc ASRT · Entity 149352 | Exercise / conversionRestricted Stock Units · Derivative | 19,512 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001005201-19-000018 · wf-form5_155017910009665.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,512 shares Expires 2018-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock. F2 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. Read SEC document |
| May 15, 2018 Filed Feb 14, 2019 21:18 UTC | Assertio Therapeutics, Inc ASRT · Entity 149352 | Exercise / conversionCommon Stock | 19,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001005201-19-000018 · wf-form5_155017910009665.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2018 Filed May 11, 2018 00:08 UTC | Assertio Therapeutics, Inc DEPO · Entity 149352 | GrantRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-006589 · edgar.xml · derivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F1 · security: Grant of restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest on May 08, 2019, assuming continued service through the applicable vesting date. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest on May 08, 2019, assuming continued service through the applicable vesting date. Read SEC document |
| May 01, 2018 Filed May 1, 2018 22:23 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | ConversionSeries D Preferred Stock · Derivative | 35,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-027185 · doc4.xml · derivative · entry 6 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 35,924 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F3 · ownership.nature: The shares were held by Spring Development Group, LLC. The reporting person is the managing member of Spring Development Group, LLC and has sole voting and dispositive power over the shares held by Spring Development Group, LLC. Read SEC document |
| May 01, 2018 Filed May 1, 2018 22:23 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | ConversionSeries D Preferred Stock · Derivative | 44,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-027185 · doc4.xml · derivative · entry 5 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 44,905 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| May 01, 2018 Filed May 1, 2018 22:23 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | ConversionSeries D Preferred Stock · Derivative | 8,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-027185 · doc4.xml · derivative · entry 4 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| May 01, 2018 Filed May 1, 2018 22:23 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | ConversionCommon Stock | 35,924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-027185 · doc4.xml · nonDerivative · entry 3 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 47,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The shares are held by Spring Development Group, LLC. The reporting person is the managing member of Spring Development Group, LLC and has sole voting and dispositive power over the shares held by Spring Development Group, LLC. Read SEC document |
| May 01, 2018 Filed May 1, 2018 22:23 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | ConversionCommon Stock | 44,905 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-027185 · doc4.xml · nonDerivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 44,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| May 01, 2018 Filed May 1, 2018 22:23 UTC | DOCUSIGN, INC. DOCU · Entity 2242 | ConversionCommon Stock | 8,981 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-027185 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series D Preferred Stock converted into one share of common stock upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 19:30 UTC | ZYNGA INC ZNGA · Entity 126967 | GrantRestricted Stock Unit · Derivative | 58,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026740 · doc4.xml · derivative · entry 3 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,139 Underlying: Class A Common Stock · 58,139 shares Expires 2025-04-26 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F3 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of July 26, 2018, October 26, 2018, and January 26, 2019, and 25% of the restricted stock units vest on the earlier of April 26, 2019 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 19:30 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 17,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026740 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17,422 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 19:30 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 17,422 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-026740 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 01, 2018 Filed Mar 15, 2018 21:16 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 17,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-020050 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,422 Underlying: Class A Common Stock · 17,421 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| February 01, 2018 Filed Mar 15, 2018 21:16 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 17,421 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-020050 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 22:09 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 29,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-17-000074 · edgardoc.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,062 F1 · kind: All of the restricted stock units vest one year from the vesting commencement date. F2 · shares: This grant is represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of ARAY common stock. Read SEC document |
| November 17, 2017 Filed Nov 18, 2017 00:38 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 9,505 | $4.80 | $45,624.00 |
DisclosureSEC source: 0001138723-17-000060 · edgardoc.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,936 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 16:13 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 17,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-059153 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,843 Underlying: Class A Common Stock · 17,422 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 16:13 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 17,422 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-059153 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 22:22 UTC | Assertio Therapeutics, Inc DEPO · Entity 149352 | GrantRestricted Stock Units · Derivative | 19,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011566 · edgar.xml · derivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,512 Underlying: Common Stock · 19,512 shares Expires not disclosed F1 · security: Grant of restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F3 · derivative.exercise_date: These restricted stock units are scheduled to vest on May 15, 2018, assuming continued service through the applicable vesting date. F3 · derivative.expiration_date: These restricted stock units are scheduled to vest on May 15, 2018, assuming continued service through the applicable vesting date. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:23 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 17,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047560 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,265 Underlying: Class A Common Stock · 17,421 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 20:23 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 17,421 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-047560 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| May 10, 2017 Filed May 12, 2017 20:47 UTC | NovoCure Ltd NVCR · Entity 4494 | GrantOptions to Buy Ordinary Shares · Derivative | 23,600 | $0.00 Strike: $12.30 | $0.00 |
DisclosureSEC source: 0001209191-17-032005 · doc4.xml · derivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,600 Underlying: Ordinary Shares · 23,600 shares Expires 2027-05-10 F1 · derivative.exercise_date: Options to buy 23,600 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the date of the Company's 2018 annual general meeting of shareholders. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:00 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 69,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-029835 · doc4.xml · derivative · entry 3 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,686 Underlying: Class A Common Stock · 69,686 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F3 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 1, 2017, November 1, 2017, and February 1, 2018, and 25% of the restricted stock units vest on the earlier of May 1, 2018 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:00 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-029835 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,084 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of September 9, 2016, December 9, 2016, and March 9, 2017 and 25% of the restricted stock units vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:00 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-029835 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 17:58 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-019944 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,084 Underlying: Class A Common Stock · 19,084 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: The restricted stock units vest as follows: 25% of the shares vest on September 9, 2016, 25% of the shares vest on December 9, 2016, 25% of the shares vest on March 9, 2017 and 25% of the shares vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 17:58 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-019944 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| December 09, 2016 Filed Dec 9, 2016 18:40 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-154526 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,168 Underlying: Class A Common Stock · 19,084 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: The restricted stock units vest as follows: 25% of the restricted stock units vest on September 9, 2016, 25% of the restricted stock units vest on December 9, 2016, 25% of the restricted stock units vest on March 9, 2017 and 25% of the restricted stock units vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| December 09, 2016 Filed Dec 9, 2016 18:40 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-154526 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| November 30, 2016 Filed Dec 3, 2016 00:06 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 23,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-16-000150 · edgardoc.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,441 F1 · kind: All of the restricted stock units vest one year from the vesting commencement date. F2 · shares: This grant is represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of ARAY common stock. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 23:26 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 6,818 | $5.30 | $36,135.40 |
DisclosureSEC source: 0001138723-16-000130 · edgardoc.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,679 F1 · shares: These shares were forfeited due to a cash settlement election made by the director in the grant agreement. Read SEC document |
| September 09, 2016 Filed Sep 9, 2016 18:50 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 19,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-140829 · doc4.xml · derivative · entry 2 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,252 Underlying: Class A Common Stock · 19,083 shares Expires 2023-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: The restricted stock units vest as follows: 25% of the shares vest on September 9, 2016, 25% of the shares vest on December 9, 2016, 25% of the shares vest on March 9, 2017 and 25% of the shares vest on the earlier of June 9, 2017 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| September 09, 2016 Filed Sep 9, 2016 18:50 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 19,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-140829 · doc4.xml · nonDerivative · entry 1 LAVIGNE LOUIS J JR · CIK 0001214127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.